We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$5.32B
AUM Growth
+$230M
Cap. Flow
-$77.7M
Cap. Flow %
-1.46%
Top 10 Hldgs %
24.47%
Holding
211
New
11
Increased
68
Reduced
63
Closed
29

Top Sells

Rank Stock Value
1
SBNY
Signature Bank
SBNY
+$41.2M
2
SMG icon
ScottsMiracle-Gro
SMG
+$35.8M
3
MIDD icon
Middleby
MIDD
+$25.5M
4
JELD icon
JELD-WEN Holding
JELD
+$20.9M
5
BABA icon
Alibaba
BABA
+$19.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.73%
2 Healthcare 17.61%
3 Financials 15.29%
4 Technology 14.85%
5 Industrials 13.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAL icon
151
TAL Education Group
TAL
$6.58B
$4.69M 0.09%
182,500
+31,000
+20% +$1M
EDIT icon
152
Editas Medicine
EDIT
$436M
$4.3M 0.08%
135,000
+15,000
+13% +$485K
MYOK
153
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$4.11M 0.08%
63,000
+10,000
+19% +$588K
MRAM icon
154
Everspin Technologies
MRAM
$415M
$3.73M 0.07%
485,000
FOMX
155
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3.67M 0.07%
640,000
+250,000
+64% +$1.43M
ITUB icon
156
Itaú Unibanco
ITUB
$81.6B
$3.64M 0.07%
682,637
BMY icon
157
Bristol-Myers Squibb
BMY
$130B
$3.17M 0.06%
51,060
-15,000
-23% -$890K
HTT
158
High Templar Tech Ltd
HTT
$391M
$3.13M 0.06%
600,000
+330,000
+122% +$2.26M
NKTR icon
159
Nektar Therapeutics
NKTR
$2.57B
$3.08M 0.06%
3,367
+1,334
+66% +$1.14M
COLM icon
160
Columbia Sportswear
COLM
$2.88B
$2.79M 0.05%
+30,000
New +$2.73M
JD icon
161
JD.com
JD
$42.7B
$2.61M 0.05%
100,000
-40,000
-29% -$1.31M
NERV icon
162
Minerva Neurosciences
NERV
$187M
$2.57M 0.05%
25,625
+10,000
+64% +$751K
JOBS
163
DELISTED
51job Inc
JOBS
$2.31M 0.04%
30,000
-75,137
-71% -$6M
JKS
164
JinkoSolar
JKS
$860M
$1.69M 0.03%
156,844
ANAB icon
165
AnaptysBio
ANAB
$1.69B
$1.6M 0.03%
16,000
EXEL icon
166
Exelixis
EXEL
$12.5B
$1.58M 0.03%
89,000
-239,000
-73% -$4.66M
BPMC
167
DELISTED
Blueprint Medicines
BPMC
$1.48M 0.03%
19,000
YUMC icon
168
Yum China
YUMC
$16.4B
$1.23M 0.02%
35,000
+10,000
+40% +$356K
JOYY
169
JOYY Inc
JOYY
$3.74B
$1.1M 0.02%
14,700
-3,000
-17% -$252K
DE icon
170
Deere & Co
DE
$167B
$1.05M 0.02%
7,000
-16,000
-70% -$2.3M
TEL icon
171
TE Connectivity
TEL
$62B
$1.04M 0.02%
11,808
-68,192
-85% -$6.27M
BMI icon
172
Badger Meter
BMI
$3.91B
$869K 0.02%
16,419
-58,581
-78% -$3.05M
K
173
DELISTED
Kellanova
K
$714K 0.01%
10,864
-240,630
-96% -$16.2M
MAN icon
174
ManpowerGroup
MAN
$2.61B
$627K 0.01%
+7,296
New +$649K
CI icon
175
Cigna
CI
$73.3B
$535K 0.01%
2,568
+1,308
+104% +$242K

Similar funds

Handelsbanken Fonder's Q3 2018 Portfolio in Review

As of Q3 2018, Handelsbanken Fonder held 211 positions worth $5.32B, up 4.5% from $5.09B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Handelsbanken Fonder's Q3 2018 filing shows 11 new, 68 increased, 63 reduced and 29 closed positions. Its largest new stake was Welbilt, Inc.: 1,288,718 shares worth $26.9M. The largest sale was Signature Bank, an estimated $41.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Handelsbanken Fonder's largest Q3 2018 buy was Welbilt, Inc.: 1,288,718 shares worth $26.9M.
  • Handelsbanken Fonder added most to Microsoft in Q3 2018, an estimated $23.3M increase.
  • Handelsbanken Fonder's biggest Q3 2018 reduction was Middleby, cutting an estimated $25.5M.
  • Handelsbanken Fonder fully exited Signature Bank in Q3 2018, selling an estimated $41.2M.
  • Handelsbanken Fonder's ten largest holdings make up 24% of its $5.32B portfolio in Q3 2018.
  • Handelsbanken Fonder opened 11 new positions and closed 29 in Q3 2018.
  • Handelsbanken Fonder's portfolio value rose 4.5% quarter-over-quarter to $5.32B.

Based on Handelsbanken Fonder's 13F filing for Q3 2018, filed 19 Oct 2018.